Registry of Lobbyists
| Organization: | Innovative Medicines Canada/Médicaments novateurs Canada |
| Associated registration: | 782797-371-69 |
| Communication date: | 2018-09-18 |
| Posted date: | 2019-11-28 |
| Designated Public Office Holders who participated in the communication: |
Karina Rolland-Sardana,
Stakeholder Relations Advisor
House of Commons |
| Subject Matter of the communication: | Health, Industry, Regional Development |
| Communication Report amended on: | 2019-11-28 previous entry: 371-435094 |
| Reason for amendment: | We removed Mr. Zylstra from the report as requested by the Office of the Commissioner of Lobbying. |
| Responsible Officer who filed this communication report: | Pamela Fralick |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |